The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-12.3% to $720.00
Predicted High$890.00at 2 months
Predicted Low$720.00at 6 months
Max Drawdown (predicted)-12.3%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 12, 2026 12:52 am
Bear
LITE trends lower to
$720.00
(-12.3% from $820.59)
by Feb 2027.
ride-then-fade
ThesisLITE rides a red-hot AI-optical narrative and post-blowout momentum into the fall on a risk-on tape, but stretched valuation (value lens -78, attractive below $450) and a 3.37 beta invite a sharp mean-reversion once the story cools or the regime wobbles. Expect near-term drift higher, a late-year peak, then partial give-back.
Invalidated ifBreak below $700 on rising volume, or a regime flip to risk-off, would falsify the near-term melt-up leg.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $820.59 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 12, 2026
—
$820.59at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 26, 2026
$662.61–$978.57typical range · internal point $848.00
—
±19.3%
7/10
Momentum and AI narrative extend post-print in risk-on tape
1 month
Sep 12, 2026
$591.66–$1,049.52typical range · internal point $865.00
—
±27.9%
6/10
Sentiment tailwind persists, no earnings catalyst near-term
2 months
Oct 12, 2026
$890.00
—
+8.5%
5/10
AI-optical bid continues, high beta amplifies risk-on
3 months
Nov 12, 2026
$870.00
—
+6.0%
4/10
Next print approaches, positioning gets crowded
4 months
Dec 12, 2026
$820.00
—
-0.1%
4/10
Valuation gravity begins asserting against stretched multiple
5 months
Jan 12, 2027
$760.00
—
-7.4%
4/10
Narrative fatigue, high beta reverses on any regime wobble
6 months
Feb 12, 2027
$720.00
—
-12.3%
3/10
Mean-reversion toward value lens attractive zone deepens
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$0.00
(+0.0%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.